Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: Apparent resistance to N -acetylcysteine supplementation

Pediatric Diabetes

Volumn 9, Issue 6, 2008, Pages 577-582

  Darmaun, Dominique ^a,b   Smith, Shiela D ^a   Sweeten, Shawn ^a   Hartman, Brenda K ^a   Welch, Susan ^a   Mauras, Nelly ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Cysteine; Nutrition; Oxidative stress; Stable isotopes

Indexed keywords

ACETYLCYSTEINE; CYSTEINE; GLUCOSE; GLUTATHIONE; HEMOGLOBIN A1C; INSULIN; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUTATHIONE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MALE; METABOLIC DISORDER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; ADOLESCENT; DEUTERIUM; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; MALE;

EID: 56649092631     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00436.x     Document Type: Article

References (31)

1. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004: 134: 489-492.
2. De Mattia G, Bravi MC, Laurenti O et al. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia 1998: 41: 1392-1396.
3. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998: 21: 1736-1742.
4. Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N. Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 2005: 54: 190-196.
5. Jain SK, Mc Vie R. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994: 43: 306-309.
6. Jain SK, Mc Vie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 1999: 48: 1850-1855.
7. Jain SK, Mc Vie R, Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care 2000: 23: 1389-1394.
8. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001: 414: 813-820.
9. Rosen P, Du X, Tschope D. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: Prevention by alpha-tocopherol? Mol Cell Biochem 1998: 188: 103-111.
10. Jahoor F, Jackson A, Gazzard B et al. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthetic rate. Am J Physiol 1999: 276: E205-E211.
11. Badaloo A, Reid M, Forrester T, Heird WC, Jahoor F. Cysteine supplementation improves the erythrocyte glutathione synthesis rate in children with severe edematous malnutrition. Am J Clin Nutr 2002: 76: 646-652.
12. Roes EM, Raijmakers MT, Peters WH, Steegers EA. Effects of N-acetylcysteine on plasma homocysteine and whole blood glutathione levels in healthy, non pregnant women. Clin Chem Lab Med 2002: 40: 496-498.
13. Fukagawa NK, Ajami AM, Young VR. Plasma methionine and cysteine kinetics in response to an intravenous glutathione infusion in adult humans. Am J Physiol 1996: 270: E209-E214.
14. Hankard R, Haymond MW, Darmaun D. Role of glutamine as a glucose precursor in fasting humans. Diabetes 1997: 46: 1535-1541.
15. Abumrad AA, Rabin D, Diamond MP, Lacy WW. Use of a heated hand vein as an alternative site for the measurement of amino acid concentrations and fro the study of glucose and alanine kinetics in man. Metabolism 1981: 30: 936-940.
16. Humbert B, Nguyen P, Martin L et al. Effect of glutamine on glutathione kinetics in vivo in dogs. J Nutr Biochem 2007: 18: 10-16.
17. 15N-glutamic acid and homoglutathione to determine both glutathione synthesis and concentration by GCMS. J Mass Spectrom 2001: 36: 726-735.
18. Lyons J, Rauh - pfeiffer A, YU YM et al. Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet. Proc Natl Acad Sci U S A 2000: 97: 5071-5076.
19. Bernard GR, Wheeler AP, Arons MM et al. A trial of antioxidants N-acetylcysteine and procysteine in Ards. The Antioxidant in Ards Study Group. Chest 1997: 112: 164-172.
20. Bridgeman MM, Marsden M, Selby C, Morrison D, Macnee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 1994: 19: 670-677.
21. Hsu CC, Yen HF, Yin MC, Tsai CM, Hsieh CH. Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J Nutr 2004: 134: 3245-3249.
22. Haber CA, Lam TK, Yu Z et al. Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J Nutr 2004: 134: 3245-3249.
23. Odetti P, Pesce C, Traverso N et al. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 2003: 52: 499-505.
24. Ozkilic AC, Cengiz M, Ozaydin A, Cobanoglu A, Kanigur G. The role of N-acetylcysteine treatment on anti-oxidative status in patients with type II diabetes mellitus. J Basic Clin Physiol Pharmacol 2006: 17: 245-254.
25. Hayes JD, Mclellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999: 31: 273-300.
26. Murakami K, Kondo T, Ohtsuka Y, Fujiwara Y, Shimada M, Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 1999: 38: 743-758.
27. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: Regulation of glutathione synthesis and efflux. Diabetologia 1995: 38: 201-210.
28. Magnusson I, Ekman L, Wangdahl M, Wahren J. N-acetyl-L-tyrosine and N-acetyl-L-cysteine as tyrosine and cysteine precursors during intravenous infusion in humans. Metabolism 1989: 38: 957-961.
29. Martensson J, Hermansson G. Sulfur amino acid metabolism in juvenile-onset nonketotic and ketotic diabetic patients. Metabolism 1984: 33: 425-428.
30. Fukagawa NK, Hercules E, Ajami AM. L-2-[13 C]oxothiazolidine-4-carboxylic acid: A probe for precursor mobilization for glutathione synthesis. Am J Physiol 2000: 278: E171-E176.
31. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002: 106: 2067-2072.